Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2021-06-23 Board/Management Inform…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
Board/Management Information Classification · 99% confidence The document is a press release announcing the departure of the Chief Scientific Officer (CSO), Dr. Piet Wigerinck. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). The text includes key phrases like 'kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan' (announces departure of CSO Piet Wigerinck) and discusses the immediate transfer of responsibilities to the Chief Medical Officer. This is a clear management change notification, not a financial report (like 10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). The document length (6978 chars) is substantial enough to be the primary announcement itself, not just a brief RPA.
2021-06-23 Dutch
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
Board/Management Information Classification · 98% confidence The document is a press release announcing the departure of the Chief Scientific Officer (CSO), Dr. Piet Wigerinck. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The document is not a full financial report (10-K or IR), an earnings release (ER), or a transcript (CT). Therefore, the appropriate classification is MANG.
2021-06-23 Dutch
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information Classification · 99% confidence The document is a press release announcing the departure of the Chief Scientific Officer (CSO), Dr. Piet Wigerinck. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). The text includes key phrases like 'kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan' (announces departure of CSO Piet Wigerinck) and discusses the immediate transfer of responsibilities to the Chief Medical Officer. This is a clear management change notification, not a financial report (like 10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). The document length (6978 chars) is substantial enough to be the primary announcement itself, not just a brief RPA.
2021-06-23 English
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information Classification · 98% confidence The document is a press release announcing the departure of the Chief Scientific Officer (CSO), Dr. Piet Wigerinck. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The document is not a full financial report (10-K or IR), an earnings release (ER), or a transcript (CT). Therefore, the appropriate classification is MANG.
2021-06-23 English
6-K Filing
Regulatory Filings
2021-06-23 English
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information Classification · 98% confidence The document is a press release titled "Galapagos announces departure of CSO Piet Wigerinck later this year." It details a change in senior management (Chief Scientific Officer departure and transition of responsibilities). This directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2021-06-22 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.